Skip to main content
  • nl
  • fr
  • en
Other official information and services: www.belgium.be
Logo of the Belgian Federal Authorities
FAMHP
Your medicine and health products
  • About the FAMHP
  • Jobs
  • Publications
  • Press
  • Contact
  • Complaints
  • Webportal
  • Home
  • Human medicines
  • Veterinary medicines
  • Information for the public
  • Notification of adverse reactions or incidents
  • Home
  • Human medicines

Human use

 

Medicines

Health Products

Particular products

Medicines

Homeopathic medicines

Herbal medicinal products

Medical devices and their accessories

Human body material

Blood and blood products

Raw materials

Specially reglemented substances

Grey area
Last updated on 15/02/2018

Notification of adverse reactions or incidents

PIL and SPC
of a medicine

(PIL: patient information leaflet SPC: summary of product characteristics)

Search

News

19/04/2018
PRAC April 2018 - Risk of dosing errors with methotrexate and unmet medical need for hydroxyethyl-starch (HES) solutions for infusion
03/04/2018
Medical devices: autocontrol and administrative simplification. End of the transition period on 17th June 2018.
30/03/2018
New online database containing all medicinal products for human and veterinary use authorised in Belgium
16/03/2018
Flash VIG-news : MANIPREX® (lithium carbonate): temporary halt to marketing that may be problematic for the treatment of certain patients
All news

© 2016 - FAMHP

  • Site map
  • Disclaimer
  • Complaints
  • Contact